Jaguar Animal Health Inc (JAGX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Jaguar Animal Health Inc (JAGX) has a cash flow conversion efficiency ratio of 0.297x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-5.54 Million) by net assets ($-18.69 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Jaguar Animal Health Inc - Cash Flow Conversion Efficiency Trend (2007–2025)
This chart illustrates how Jaguar Animal Health Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Jaguar Animal Health Inc total liabilities for a breakdown of total debt and financial obligations.
Jaguar Animal Health Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jaguar Animal Health Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Merino & Co. Ltd
AU:MNC
|
-0.297x |
|
Pulmatrix Inc
NASDAQ:PULM
|
-0.218x |
|
Global Engine Group Holding Limited Ordinary Shares
NASDAQ:GLE
|
-0.028x |
|
Nutritional Growth Solutions Ltd
AU:NGS
|
-2.363x |
|
THREED CAPITAL INC.
F:B5K3
|
N/A |
|
Sentral Mitra Informatika Tbk PT
JK:LUCK
|
-0.026x |
|
AS Rigas kugu buvetava
STU:UW3
|
-0.045x |
|
Riedel Resources Ltd
AU:RIE
|
-0.102x |
Annual Cash Flow Conversion Efficiency for Jaguar Animal Health Inc (2007–2025)
The table below shows the annual cash flow conversion efficiency of Jaguar Animal Health Inc from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see Jaguar Animal Health Inc market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $-18.69 Million | $5.80 Million | -0.310x | +93.14% |
| 2024-12-31 | $6.49 Million | $-29.38 Million | -4.525x | +33.34% |
| 2023-12-31 | $4.90 Million | $-33.24 Million | -6.788x | -127.81% |
| 2022-12-31 | $-1.36 Million | $-33.10 Million | 24.413x | +927.47% |
| 2021-12-31 | $11.85 Million | $-34.97 Million | -2.950x | -232.18% |
| 2020-12-31 | $17.20 Million | $-15.28 Million | -0.888x | +53.66% |
| 2019-12-31 | $10.67 Million | $-20.46 Million | -1.917x | +54.61% |
| 2018-12-31 | $5.38 Million | $-22.73 Million | -4.223x | -641.85% |
| 2017-12-31 | $17.26 Million | $-9.82 Million | -0.569x | -109.69% |
| 2016-12-31 | $-2.45 Million | $-14.41 Million | 5.873x | +280.47% |
| 2015-12-31 | $4.40 Million | $-14.32 Million | -3.254x | +34.70% |
| 2014-12-31 | $1.10 Million | $-5.46 Million | -4.984x | -46.54% |
| 2007-12-31 | $5.40 Million | $-18.37 Million | -3.401x | -- |
About Jaguar Animal Health Inc
Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. The company operates through two segments, Animal Health and Human Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products. T… Read more